Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure
NCT ID: NCT06400927
Last Updated: 2024-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-05-07
2027-09-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Voice Analysis for Monitoring Patients With Heart Failure
NCT06566911
Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure
NCT06847906
Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation
NCT06555757
Artificial Intelligence and Smart Wearable Technologies for Early Detection of Acute Heart Failure
NCT05591443
Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management
NCT02673073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VA-guided arm
HF-guided VA
VA guided recommendation
Standard-of-care arm
Standard-of-care
Standard-of-care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HF-guided VA
VA guided recommendation
Standard-of-care
Standard-of-care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge
Exclusion Criteria
* Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
* Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
* Dementia or other cognitive impairment
* Currently involved in another interventional clinical trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy
UNKNOWN
East and North Hertfordshire NHS Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Diana Gorog
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana A Gorog, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
East and North Hertfordshire NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East and North Hertfordshire NHS Trust
Stevenage, Hertfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD2024-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.